Preferences of German melanoma patients for interferon (IFN) α-2b toxicities (the DeCOG “GERMELATOX survey”) versus melanoma recurrence to quantify patients’ relative values for adjuvant therapy
暂无分享,去创建一个
J. Utikal | A. Hauschild | D. Schadendorf | L. Heinzerling | C. Garbe | R. Gutzmer | Tobias Wagner | M. Augustin | C. Blome | A. Forschner | E. Livingstone | C. Loquai | P. Terheyden | B. Lang | K. Kaehler | L. V. Maul | T. Haalck | T. Kornek | B. Stade